Objective To investigate the effects of anti-HBV specific active immunotherapy on non-responsive persons immunized with standard recombinant hepatitis B vaccine.
目的探讨抗HBV特异性主动免疫疗法对标准重组乙型肝炎（乙肝）疫苗无应答者的免疫效果。
It's called a recombinant protein vaccine and USES an influenza virus protein that's made by genetically altering a virus that infects insect cells.
这种疫苗被称作“重组蛋白疫苗”，它采用了一种流感病毒蛋白质，这种蛋白质是通过改变一种感染昆虫细胞的病毒的基因而合成的。
Conclusion: Recombinant T7 phage vaccine expressing xenogenic VEGF can break immunologic tolerance against self-VEGF and induce the producing of specific anti-VEGF antibody.
结论：异种血管内皮生长因子基因重组T7噬菌体疫苗可打破机体对自身vegf的免疫耐受，诱导产生较高水平的特异性抗vegf抗体。
Objective:To construct a recombinant plasmid containing rhoptry protein 2(ROP2)gene of Toxoplasma gondii and express it in E. coli for selection of diagnostic antigen and vaccine candidate.
目的：构建弓形虫棒状体蛋白（ROP2 ）基因重组质粒并在大肠杆菌中表达，用于筛选弓形虫新的诊断抗原和疫苗分子。
Objective to developed a recombinant protein vaccine with epitopes on VP1 protein for prevention of foot-and-mouth disease virus (FMDV) spreading by inactive-FMD vaccine.
目的为了克服灭活口蹄疫病毒疫苗可能存在的传播病毒的潜在危险，构建一种能预防O型口蹄疫病毒感染的VP1表位重组蛋白疫苗。
To assess the immunogenecity and efficacy of the yeast recombinant hepatitis B vaccine (YHB vaccine) for the prevention of hepatitis B in the newborns.
评价接种酵母重组乙肝疫苗（基因疫苗）的免疫效果与免疫持久性，为基因疫苗的推广应用及高危新生儿乙型肝炎的预防提供依据。
Therefore, the recombinant could be a vaccine candidate of Vibrio cholera.
因此，该重组菌苗可能成为霍乱弧菌很好的菌苗候选株。
Recombinant BCG vaccine of micro organisms could be used in the prevention and treatment in diseases caused by bacteria, viruses and borrelia. Its prospects are summarized in this review.
本文综述了细菌、病毒和螺旋体等微生物的重组BCG疫苗及其运用前景。
The successful expression of HEV ORF2 protein in p. Pastoris and the production of recombinant protein provides basis for genetically engineered vaccine development of hepatitis E.
HEV结构区ORF2蛋白在甲醇营养型酵母中的成功表达，以及初步纯化得到的具有强免疫学活性的重组蛋白，为研制新型戊型肝炎基因工程疫苗奠定了基础。
In the invention, the recombinant plasmodium is also applied to biological therapy and vaccine design, in particular to the biological therapy of tumors and the design of HIV vaccine.
本发明还将该重组疟原虫应用于生物治疗和疫苗设计中，尤其是肿瘤的生物治疗和HIV疫苗的设计。
Objective:To investigate the antibody response to hepatitis B vaccination and the necessity of reinforcement of recombinant hepatitis B vaccine (RHBV) at 12 month.
目的：探讨重组酵母乙肝疫苗新生儿接种后抗体应答持续时间，强化复种的必要性。
The invention discloses a brucella melitensis immune labeled recombinant strain and the application thereof in the preparation of vaccine.
本发明公开了一种羊种布鲁氏菌免疫标记重组菌株及其应用。
The purified recombinant major outer-membrane protein (MOMP) of Chlamydia psittaci(Cps)expressed in E. coli was mixed with oil adjuvant and manufactured as MOMP-vaccine.
利用鹦鹉热衣原体重组主要外膜蛋白（MOMP）在大肠杆菌中的表达产物，纯化后与白油佐剂乳化成疫苗。
The invention provides a process for preparing the recombinant BCG vaccine, researches the immunity thereof, and belongs to the field of gene engineering and the field of tuberculosis vaccine.
本发明提供了一种重组卡介苗的制备过程，并研究了其免疫性，属于基因工程领域和结核疫苗领域。
Piglets of each groups were vaccinated respectively with recombinant protein vaccine, commodity vaccine and PBS as contrast. The serum IgG anti-protein of each groups were detected by indirect ELISA.
分别以重组蛋白疫苗、商品疫苗和PBS免疫仔猪，优化检测免疫抗体水平的间接ELISA条件，通过比较三个免疫组的抗体水平来评价表达蛋白作为免疫抗原的有效性。
Piglets of each groups were vaccinated respectively with recombinant protein vaccine, commodity vaccine and PBS as contrast. The serum IgG anti-protein of each groups were detected by indirect ELISA.
分别以重组蛋白疫苗、商品疫苗和PBS免疫仔猪，优化检测免疫抗体水平的间接ELISA条件，通过比较三个免疫组的抗体水平来评价表达蛋白作为免疫抗原的有效性。
应用推荐